Zai Lab Announces Upcoming Presentations in October Investor Conferences

Rhea-AI Summary

Zai Lab, a biopharmaceutical company, will present at two upcoming virtual investor conferences in October 2021. They will participate in the J.P. Morgan Global Healthcare Conference on October 13 at 9:30 a.m. HKT and the Jefferies China Biotech Virtual Summit on October 26 at 8:30 a.m. EDT. A live webcast for the Jefferies summit will be available on Zai Lab’s website, with a replay accessible for 90 days. Zai Lab focuses on developing therapies for unmet medical needs in oncology, autoimmune disorders, and infectious diseases.

SHANGHAI and SAN FRANCISCO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following upcoming virtual investor conferences in October:

J.P. Morgan Global Healthcare Conference, Shanghai Forum
Fireside Chat: Wednesday, October 13, 2021 at 9:30 a.m. HKT

Jefferies China Biotech Virtual Summit
Presentation: Tuesday, October 26, 2021 at 8:30 a.m. EDT

A live webcast of Jefferies China Biotech Virtual Summit will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 90 days following the event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders and infectious disease. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and product candidates. We have also built an in-house team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to impact human health worldwide.

For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

ZAI LAB CONTACTS:

Investor Relations: Ron Aldridge / Lina Zhang
+1 (781) 434-8465 / +86 136 8257 6943
ronald.aldridge@zailaboratory.com / lina.zhang@zailaboratory.com

Media: Danielle Halstrom / Xiaoyu Chen
+1 (215) 280-3898 / +86 185 0015 5011
danielle.halstrom@zailaboratory.com / xiaoyu.chen@zailaboratory.com 

Zai Lab Limited

Source: Zai Lab Limited

FAQ

What is Zai Lab's presentation schedule for October 2021?

Zai Lab will present at the J.P. Morgan Global Healthcare Conference on October 13 at 9:30 a.m. HKT and at the Jefferies China Biotech Virtual Summit on October 26 at 8:30 a.m. EDT.

Where can I watch Zai Lab’s presentations?

Zai Lab's presentations will be available as live webcasts on their website, specifically under 'Events & Presentations'.

What is the focus of Zai Lab's research and development?

Zai Lab focuses on developing therapies for unmet medical needs in oncology, autoimmune disorders, and infectious diseases.

How long will the webcast of the Jefferies summit be available?

The webcast of the Jefferies China Biotech Virtual Summit will be available for 90 days after the event.